74 phenotypes from 6 alleles in 10 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Lipetm1b(KOMP)Wtsi/Lipetm1b(KOMP)Wtsi C57BL/6N-Lipetm1b(KOMP)Wtsi/Ucd	abnormal heart morphology	J:211773
	enlarged heart	J:211773
	hyperactivity	J:211773
	increased bone mineral density	J:211773
	increased circulating insulin level	J:211773
	increased kidney weight	J:211773
	male infertility	J:211773
Lipetm1Gam/Lipe+ involves: 129S4/SvJae	reduced male fertility	J:71782
Lipetm1Gam/Lipetm1Gam involves: 129S4/SvJae	abnormal epididymis morphology	J:71782
	abnormal seminiferous tubule epithelium morphology	J:71782
	abnormal spermatid morphology	J:71782
	abnormal spermiogenesis	J:71782
	azoospermia	J:71782
	decreased male germ cell number	J:71782
	decreased testis weight	J:71782
	male infertility	J:71782
Lipetm1Gam/Lipetm1Gam involves: 129S4/SvJae * BALB/c	abnormal abdominal fat pad morphology	J:82299
	abnormal circulating cholesterol level	J:82299
	abnormal circulating free fatty acids level	J:82299
	abnormal fat cell morphology	J:82299
	decreased circulating leptin level	J:82299
	decreased liver triglyceride level	J:82299
	increased brown adipose tissue amount	J:82299
	increased circulating glucose level	J:82299
Lipetm1Ishi/Lipetm1Ishi B6.129S7-Lipetm1Ishi	abnormal cholesterol homeostasis	J:152385
	increased circulating cholesterol level	J:152385
	increased circulating free fatty acids level	J:152385
	increased circulating glucose level	J:152385
	increased circulating triglyceride level	J:152385
Lipetm1Ishi/Lipetm1Ishi involves: 129S7/SvEvBrd * C57BL/6	abnormal brown adipose tissue morphology	J:59889
	abnormal enzyme/coenzyme activity	J:59889
	abnormal seminiferous tubule epithelium morphology	J:59889
	abnormal testis morphology	J:59889
	abnormal white adipose tissue morphology	J:59889
	abnormal white adipose tissue physiology	J:59889
	asthenozoospermia	J:59889
	decreased circulating free fatty acids level	J:59889
	decreased circulating glycerol level	J:59889
	normal growth/size/body region phenotype	J:59889
	increased fat cell size	J:59889
	increased triglyceride level	J:59889
	male infertility	J:59889
	oligozoospermia	J:59889
	small testis	J:59889
Lipetm1Land/Lipetm1Land involves: 129	abnormal lipid homeostasis	J:106148
	decreased skeletal muscle glycogen level	J:106148
Lipetm1Land/Lipetm1Land involves: 129 * C57BL/6J	abnormal adipose tissue physiology	J:85540
	abnormal feces composition	J:133126
	abnormal lipolysis	J:85540
	abnormal white fat cell morphology	J:133126
	decreased body weight	J:133126
	decreased circulating adiponectin level	J:133126
	decreased circulating leptin level	J:133126
	decreased muscle cell glucose uptake	J:85540
	decreased subcutaneous adipose tissue amount	J:133126
	decreased susceptibility to diet-induced obesity	J:133126
	decreased white adipose tissue amount	J:133126
	hyperglycemia	J:85540
	increased circulating insulin level	J:85540
	increased food intake	J:133126
	increased oxygen consumption	J:133126
	increased pancreatic beta cell mass	J:85540
	insulin resistance	J:85540
	male infertility	J:85540
	oligozoospermia	J:85540
	pancreatic islet hyperplasia	J:85540
Lipetm1Rze/Lipetm1Rze involves: 129P2/OlaHsd	abnormal hepatic glucose production	J:84822
	decreased circulating adiponectin level	J:84822
	decreased circulating free fatty acids level	J:84822
	decreased circulating insulin level	J:84822
	decreased circulating triglyceride level	J:84822
	decreased liver triglyceride level	J:84822
	increased circulating glucose level	J:84822
Lipetm1Rze/Lipetm1Rze involves: 129P2/OlaHsd * C57BL/6J	abnormal brown adipose tissue physiology	J:74644
	abnormal fatty acids level	J:74644
	abnormal lipid level	J:74644
	abnormal metabolism	J:74644
	abnormal triglyceride level	J:74644
	abnormal white adipose tissue physiology	J:74644
	decreased cardiac muscle triglyceride level	J:74644
	decreased liver triglyceride level	J:74644
	increased triglyceride level	J:74644
Lipetm2Rze/Lipetm2Rze Tg(Ins2-cre)25Mgn/? involves: 129 * C57BL/6 * DBA	abnormal glucose homeostasis	J:144744
	abnormal insulin secretion	J:144744
	abnormal pancreatic beta cell morphology	J:144744
	decreased lean body mass	J:144744
	impaired glucose tolerance	J:144744
	increased circulating glucose level	J:144744
	increased circulating leptin level	J:144744
	increased pancreatic beta cell mass	J:144744
	increased percent body fat/body weight	J:144744